中国医药生物技术
中國醫藥生物技術
중국의약생물기술
CHINESE MEDICINAL BIOTECHNOLOGY
2014年
5期
321-327
,共7页
张群%庞国进%刘天会%王萍%马雪梅%尤红%丛敏
張群%龐國進%劉天會%王萍%馬雪梅%尤紅%叢敏
장군%방국진%류천회%왕평%마설매%우홍%총민
RNA干扰%转染%T淋巴细胞
RNA榦擾%轉染%T淋巴細胞
RNA간우%전염%T림파세포
RNA interference%Transfection%T-lymphocytes
目的探讨人工合成 RNA转染人外周血原代 T淋巴细胞的有效方法。方法从人外周血分离原代 T淋巴细胞,采用 Lipofectamine 2000、Lipofectamine RNAiMAX、FuGENE6、Hiperfect和 EntransterTM-R 5种不同转染试剂介导荧光标记的 RNA转染原代 T淋巴细胞,通过荧光显微镜观察及流式细胞术检测进行转染效率评价。结果分离的人外周血原代 T淋巴细胞的纯度达到87.4%。采用上述5种转染试剂介导荧光标记的 RNA转染 T淋巴细胞,24 h后转染效率分别为(14.81±1.03)%、(14.33±1.24)%、(2.10±0.16)%、(1.69±0.08)%、(72.24±1.26)%。采用 EntransterTM-R转染100及50 nmol/L对照 RNA,24 h后转染效率分别为73.7%和56.0%;EntransterTM-R转染100 nmol/L对照 RNA后48、72 h荧光标记细胞阳性率分别为62.0%、56.6%。结论转染试剂 EntransterTM-R可有效介导人工合成 RNA转染人外周血原代 T淋巴细胞。
目的探討人工閤成 RNA轉染人外週血原代 T淋巴細胞的有效方法。方法從人外週血分離原代 T淋巴細胞,採用 Lipofectamine 2000、Lipofectamine RNAiMAX、FuGENE6、Hiperfect和 EntransterTM-R 5種不同轉染試劑介導熒光標記的 RNA轉染原代 T淋巴細胞,通過熒光顯微鏡觀察及流式細胞術檢測進行轉染效率評價。結果分離的人外週血原代 T淋巴細胞的純度達到87.4%。採用上述5種轉染試劑介導熒光標記的 RNA轉染 T淋巴細胞,24 h後轉染效率分彆為(14.81±1.03)%、(14.33±1.24)%、(2.10±0.16)%、(1.69±0.08)%、(72.24±1.26)%。採用 EntransterTM-R轉染100及50 nmol/L對照 RNA,24 h後轉染效率分彆為73.7%和56.0%;EntransterTM-R轉染100 nmol/L對照 RNA後48、72 h熒光標記細胞暘性率分彆為62.0%、56.6%。結論轉染試劑 EntransterTM-R可有效介導人工閤成 RNA轉染人外週血原代 T淋巴細胞。
목적탐토인공합성 RNA전염인외주혈원대 T림파세포적유효방법。방법종인외주혈분리원대 T림파세포,채용 Lipofectamine 2000、Lipofectamine RNAiMAX、FuGENE6、Hiperfect화 EntransterTM-R 5충불동전염시제개도형광표기적 RNA전염원대 T림파세포,통과형광현미경관찰급류식세포술검측진행전염효솔평개。결과분리적인외주혈원대 T림파세포적순도체도87.4%。채용상술5충전염시제개도형광표기적 RNA전염 T림파세포,24 h후전염효솔분별위(14.81±1.03)%、(14.33±1.24)%、(2.10±0.16)%、(1.69±0.08)%、(72.24±1.26)%。채용 EntransterTM-R전염100급50 nmol/L대조 RNA,24 h후전염효솔분별위73.7%화56.0%;EntransterTM-R전염100 nmol/L대조 RNA후48、72 h형광표기세포양성솔분별위62.0%、56.6%。결론전염시제 EntransterTM-R가유효개도인공합성 RNA전염인외주혈원대 T림파세포。
Objective To investigate the efficient way by which synthetic RNA could be transfected into human primary T-lymphocytes of peripheral blood. Method Primary T-lymphocytes were separated from human peripheral blood. Isolated T-lymphocytes were transfected with fluorescently labeled RNA by different transfection reagents including Lipofectamine 2000, Lipofectamine RNAiMAX, FuGENE6, Hiperfect and EntransterTM-R. Transfection efficiency of each transfection reagent was assessed by fluorescence microscopy and further determined by flow cytometry. Result The purity of isolated T-lymphoctyes was 87.4%. Twenty four hours after fluorescently labeled RNA tranfected T lymphocytes by Lipofectamine 2000, Lipofectamine RNAiMAX, FuGENE6, Hiperfect and EntransterTM-R, transfection efficiency was (14.81 ± 1.03)%, (14.33 ± 1.24)%, (2.10 ± 0.16)%, (1.69 ± 0.08)%, (72.24 ± 1.26)%, respectively. When fluorescently labeled RNA of 100 and 50 nmol/L tranfectd T-lymphocytes by EntransterTM-R, transfection efficiency detected by flow cytometry 24 hours later were 73.7% and 56.0%,respectively. Forty eight hours and seventy two hours after 100 nmol/L fluorescently labeled RNA transfection by EntransterTM-R, the percentage of fluorescence positive cells detected by flow cytometry were 62.0% and 56.6%, respectively. Conclusion Synthetic RNA could be efficiently transfected into human primary T lymphocytes of peripheral blood by EntransterTM-R.